Assignee
ONYX THERAPEUTICS INC
US·33 granted patents·20 pending applications·355 citations·filing 2005–2022
Top patents by PatentIndex Score
53 records- 0198US7691852B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2007·Granted Apr 6, 2010·65 cites·4 claims
- 0297US8431571B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Apr 30, 2013·33 cites·46 claims
- 0397US8357683B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2011·Granted Jan 22, 2013·34 cites·22 claims
- 0496US8367617B2Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxidesONYX THERAPEUTICS INC·Filed 2008·Granted Feb 5, 2013·34 cites·8 claims
- 0593US9511109B2Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·10 cites·5 claims
- 0693US7737112B2Composition for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2005·Granted Jun 15, 2010·87 cites·32 claims
- 0790US9434761B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted Sep 6, 2016·13 cites·20 claims
- 0890US8609654B1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 17, 2013·8 cites·60 claims
- 0989US9205125B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·48 claims
- 1089US9205126B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·40 claims
- 1189US9205124B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·34 claims
- 1288US10159746B2Cyclodextrin complexation methods for formulating peptide proteasome inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Dec 25, 2018·14 cites·30 claims
- 1387US9051353B2Crystalline tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Jun 9, 2015·7 cites·14 claims
- 1486US8921583B2Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxidesONYX THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·7 cites·16 claims
- 1582US9315542B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·4 cites·30 claims
- 1679US10647744B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted May 12, 2020·2 cites·38 claims
- 1778US2021179663A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1877US8921324B2Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxidesONYX THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·2 cites·15 claims
- 1976US9309283B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Apr 12, 2016·2 cites·54 claims
- 2076US8765745B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Jul 1, 2014·1 cites·100 claims
- 2174US2020071356A1Compounds for proteasomeONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2273US9657057B2Dipeptide and tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted May 23, 2017·2 cites·21 claims
- 2372US2019211058A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2471US10022326B2Liposomal compositions of epoxyketone-based proteasome inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Jul 17, 2018·4 cites·26 claims
- 2569US11078233B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·27 claims
- 2669US2014342977A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2769US2018170962A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2868US2020254051A1Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2967US9295708B2Modified release formulations for oprozomibONYX THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·2 cites·6 claims
- 3067US2023235406A1Immunoglobulin expression levels as biomarker for proteasome inhibitor responseONYX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3167US2011236428A1Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3266US10150794B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·0 cites·1 claims
- 3366US2014100169A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3466US2014080753A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3565US8735441B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted May 27, 2014·0 cites·26 claims
- 3664US10682419B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2018·Granted Jun 16, 2020·0 cites·19 claims
- 3764US2013324459A1Compounds For Enzyme InhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3864US2016222057A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3963USRE47302EPeptide epoxyketone immunoproteasome inhibitorsONYX THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·0 cites·31 claims
- 4062USRE47954ECombination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·0 cites·17 claims
- 4162US2020289606A1Peptide epoxyketone proteasome inhibitors in combination with pim kinase inhibitors for treatment of cancersONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4262US2015361134A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4361US10596222B2Combination therapy with peptide epoxyketonesONYX THERAPEUTICS INC·Filed 2016·Granted Mar 24, 2020·0 cites·6 claims
- 4461US9657058B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·0 cites·15 claims
- 4560US2021238691A1Immunoglobulin expression levels as biomarker for proteasome inhibitor responseONYX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4659US2016083421A1Compunds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4756US9878047B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·0 cites·13 claims
- 4855US9403868B2Crystalline tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·0 cites·11 claims
- 4952US10870889B2Immunoglobulin expression levels as biomarker for proteasome inhibitor responseONYX THERAPEUTICS INC·Filed 2014·Granted Dec 22, 2020·0 cites·13 claims
- 5052US2014364377A1Use of peptide epoxyketones for metastasis suppressionONYX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →